Mariano Provencio
Department of Medical Oncology
Hospital Universitario Clínica Puerta de Hierro-Majadahonda
Madrid
Spain
Name/email consistency: high
- New molecular targeted therapies integrated with radiation therapy in lung cancer. Provencio, M., Sánchez, A., Garrido, P., Valcárcel, F. Clin. Lung. Cancer (2010)
- Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era. Provencio, M., Martín, P., García, V., Candia, A., Sánchez, A.C., Bellas, C. Leuk. Lymphoma (2010)
- Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential? Provencio, M., de Las Peñas, R., Camps, C., Artal, A., Massuti, B., Cobo, M., Pérez, F.J., Sánchez, A., Rosell, R. Lung. Cancer (2010)
- A prospective study of left ventricle function after treatment with rapid-infusion rituximab in patients with non-Hodgkin lymphoma. Provencio, M., Sanchez, A., Maximiano, C., Cantos, B., Méndez, M., Bonilla, F. Leuk. Lymphoma (2009)